CNS Pharmaceuticals, Inc. short interest in 2024
In 2024, CNS Pharmaceuticals, Inc.'s disclosed short interest ran from 1.95% of shares outstanding on 15 Feb 2024 to 2.33% on 13 Dec 2024, a change of +0.38 percentage points. The year's high was 3.54% on 31 Oct 2024 and its low 0.22% on 15 Apr 2024, averaging 1.45% across 15 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 1.00 days on 15 Feb 2024. Full history: CNS Pharmaceuticals, Inc..
Cite this page
By year: 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2024 in figures
- Start of year
- 1.95% (15 Feb 2024)
- End of year
- 2.33% (13 Dec 2024)
- Change
- +0.38 pp
- High
- 3.54% (31 Oct 2024)
- Low
- 0.22% (15 Apr 2024)
- Average
- 1.45%
- Highest days to cover
- 1.00 (15 Feb 2024)
- SEC filings marked
- 6
Every report in 2024
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 15 Feb 2024 | 1.95% | 1.00 | |
| 29 Feb 2024 | 1.03% | 1.00 | |
| 15 Mar 2024 | 1.98% | 1.00 | |
| 28 Mar 2024 | 0.95% | 1.00 | |
| 15 Apr 2024 | 0.22% | 1.00 | 10-K filed, results (8-K) |
| 30 Apr 2024 | 0.29% | 1.00 | |
| 15 May 2024 | 0.59% | 1.00 | 10-Q filed |
| 15 Aug 2024 | 0.34% | 1.00 | results (8-K), 10-Q filed |
| 30 Aug 2024 | 0.63% | 1.00 | |
| 13 Sep 2024 | 1.13% | 1.00 | |
| 30 Sep 2024 | 2.11% | 1.00 | |
| 15 Oct 2024 | 3.47% | 1.00 | |
| 31 Oct 2024 | 3.54% | 1.00 | |
| 15 Nov 2024 | 1.19% | 1.00 | 10-Q filed |
| 13 Dec 2024 | 2.33% | 1.00 |
See also: CNS Pharmaceuticals, Inc.'s full history · most shorted US stocks of 2024 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.